Odomzo

Active Ingredient(s): Sonidegib
FDA Approved: * July 24, 2015
Pharm Company: * NOVARTIS PHARMS CORP
Category: Cancer

Sonidegib (INN), sold under the brand name Odomzo, is a medication used to treat cancer.[2] Sonidegib is Hedgehog signaling pathway inhibitor (via smoothened antagonism).[3][4] Contents 1 Approvals and indications 2 Pharmacology 3 Development 4 References 5 External links Approvals and indications It was approved for medical use in the United States and in the European Union in 2015[5][6][7]... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Odomzo 200 mg Oral Capsule
NDC: 0078-0645
Labeler:
Novartis Pharmaceuticals Corporation
Odomzo 200 mg Oral Capsule
NDC: 47335-303
Labeler:
Sun Pharma Global Fze